Suppr超能文献

艰难梭菌毒素免疫检测阳性与聚合酶链反应检测结果阳性的血液系统恶性肿瘤患者的临床特征和结局。

Clinical Characteristics and Outcomes of Hematologic Malignancy Patients With Positive Clostridium difficile Toxin Immunoassay Versus Polymerase Chain Reaction Test Results.

机构信息

1Division of Infectious Diseases,Department of Healthcare Epidemiology,Infection Prevention and Control Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.

2Division of Hematology and Oncology,Department of Healthcare Epidemiology,Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.

出版信息

Infect Control Hosp Epidemiol. 2018 Jul;39(7):863-866. doi: 10.1017/ice.2018.83. Epub 2018 Apr 25.

Abstract

In a cohort of inpatients with hematologic malignancy and positive enzyme immunoassay (EIA) or polymerase chain reaction (PCR) Clostridium difficile tests, we found that clinical characteristics and outcomes were similar between these groups. The method of testing is unlikely to predict infection in this population, and PCR-positive results should be treated with concern.Infect Control Hosp Epidemiol 2018;863-866.

摘要

在一组患有血液恶性肿瘤且酶免疫测定 (EIA) 或聚合酶链反应 (PCR) 艰难梭菌检测阳性的住院患者中,我们发现这些组之间的临床特征和结局相似。检测方法不太可能预测该人群中的感染,并且应该对 PCR 阳性结果给予关注。感染控制与医院流行病学 2018;863-866.

相似文献

5
The evaluation of Clostridium difficile infection (CDI) in a community hospital.社区医院艰难梭菌感染(CDI)的评估。
J Infect Public Health. 2015 Mar-Apr;8(2):155-60. doi: 10.1016/j.jiph.2014.08.002. Epub 2014 Oct 6.

引用本文的文献

3
An Update on Binary Toxin.二元毒素更新
Toxins (Basel). 2022 Apr 27;14(5):305. doi: 10.3390/toxins14050305.

本文引用的文献

8
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.艰难梭菌感染的诊断、治疗和预防指南。
Am J Gastroenterol. 2013 Apr;108(4):478-98; quiz 499. doi: 10.1038/ajg.2013.4. Epub 2013 Feb 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验